

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.10617662 |
| 2 | piRNA metabolic process (GO:0034587) | 4.33872072 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.19136046 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19136046 |
| 5 | regulation of ARF protein signal transduction (GO:0032012) | 4.09460321 |
| 6 | positive thymic T cell selection (GO:0045059) | 4.01908712 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98964372 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.98964372 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.78123709 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73500779 |
| 11 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.71954587 |
| 12 | positive regulation of histone deacetylation (GO:0031065) | 3.66848550 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64035900 |
| 14 | negative regulation of hormone metabolic process (GO:0032351) | 3.53486027 |
| 15 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.53486027 |
| 16 | positive regulation of Rap GTPase activity (GO:0032854) | 3.46466909 |
| 17 | response to muramyl dipeptide (GO:0032495) | 3.43847909 |
| 18 | thymic T cell selection (GO:0045061) | 3.42256040 |
| 19 | tolerance induction (GO:0002507) | 3.39151838 |
| 20 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.32968783 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28318078 |
| 22 | regulation of meiosis I (GO:0060631) | 3.26961374 |
| 23 | mannose metabolic process (GO:0006013) | 3.23291633 |
| 24 | regulation of meiosis (GO:0040020) | 3.20424657 |
| 25 | growth hormone receptor signaling pathway (GO:0060396) | 3.14479859 |
| 26 | type B pancreatic cell development (GO:0003323) | 3.12295239 |
| 27 | male meiosis (GO:0007140) | 3.06160050 |
| 28 | protein localization to endosome (GO:0036010) | 3.04451473 |
| 29 | positive T cell selection (GO:0043368) | 3.03262950 |
| 30 | negative regulation of inclusion body assembly (GO:0090084) | 3.01010950 |
| 31 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.00988437 |
| 32 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.97557194 |
| 33 | leukocyte aggregation (GO:0070486) | 2.97508067 |
| 34 | histone H3-K36 demethylation (GO:0070544) | 2.96894959 |
| 35 | regulation of cholesterol homeostasis (GO:2000188) | 2.95086943 |
| 36 | regulation of female gonad development (GO:2000194) | 2.93805858 |
| 37 | response to laminar fluid shear stress (GO:0034616) | 2.89258257 |
| 38 | cellular response to growth hormone stimulus (GO:0071378) | 2.87795037 |
| 39 | histone H3-K9 demethylation (GO:0033169) | 2.87354830 |
| 40 | T cell selection (GO:0045058) | 2.87251776 |
| 41 | signal complex assembly (GO:0007172) | 2.87159128 |
| 42 | germinal center formation (GO:0002467) | 2.86903848 |
| 43 | histone H2A monoubiquitination (GO:0035518) | 2.81729412 |
| 44 | glandular epithelial cell development (GO:0002068) | 2.81603217 |
| 45 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.81118789 |
| 46 | protein targeting to Golgi (GO:0000042) | 2.79882650 |
| 47 | negative thymic T cell selection (GO:0045060) | 2.77917328 |
| 48 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.74577522 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73974116 |
| 50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73650926 |
| 51 | regulation of Rap GTPase activity (GO:0032317) | 2.73344349 |
| 52 | negative T cell selection (GO:0043383) | 2.73038554 |
| 53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.71540110 |
| 54 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.71193694 |
| 55 | establishment of protein localization to Golgi (GO:0072600) | 2.70169351 |
| 56 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68559866 |
| 57 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68559866 |
| 58 | modulation by symbiont of host immune response (GO:0052553) | 2.68559866 |
| 59 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68559866 |
| 60 | modulation by symbiont of host defense response (GO:0052031) | 2.68559866 |
| 61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68559866 |
| 62 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.68149444 |
| 63 | response to interleukin-15 (GO:0070672) | 2.67802109 |
| 64 | positive regulation of granulocyte differentiation (GO:0030854) | 2.67161354 |
| 65 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.66528033 |
| 66 | regulation of cilium assembly (GO:1902017) | 2.64873510 |
| 67 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.64117611 |
| 68 | macrophage activation involved in immune response (GO:0002281) | 2.62447150 |
| 69 | histone demethylation (GO:0016577) | 2.60973639 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.60069909 |
| 71 | sperm capacitation (GO:0048240) | 2.59184267 |
| 72 | regulation of Rab GTPase activity (GO:0032313) | 2.58699406 |
| 73 | positive regulation of Rab GTPase activity (GO:0032851) | 2.58699406 |
| 74 | sexual reproduction (GO:0019953) | 2.58176997 |
| 75 | synaptonemal complex assembly (GO:0007130) | 2.57556808 |
| 76 | detection of bacterium (GO:0016045) | 2.57315048 |
| 77 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.56904571 |
| 78 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.56531749 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.56141695 |
| 80 | RNA destabilization (GO:0050779) | 2.55492248 |
| 81 | histone lysine demethylation (GO:0070076) | 2.55233339 |
| 82 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.54699017 |
| 83 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.53347756 |
| 84 | positive regulation of type 2 immune response (GO:0002830) | 2.53248800 |
| 85 | gene silencing by RNA (GO:0031047) | 2.52263660 |
| 86 | histone H3 deacetylation (GO:0070932) | 2.51968564 |
| 87 | detection of other organism (GO:0098543) | 2.51092459 |
| 88 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.50666428 |
| 89 | synaptonemal complex organization (GO:0070193) | 2.50378513 |
| 90 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.49982934 |
| 91 | regulation of meiotic cell cycle (GO:0051445) | 2.49454014 |
| 92 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.47564041 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.46525061 |
| 94 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.45671394 |
| 95 | histone H4 deacetylation (GO:0070933) | 2.44547625 |
| 96 | macroautophagy (GO:0016236) | 2.44411543 |
| 97 | regulation of extracellular matrix disassembly (GO:0010715) | 2.43725443 |
| 98 | negative regulation of viral release from host cell (GO:1902187) | 2.43443352 |
| 99 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.43349560 |
| 100 | histone H2A ubiquitination (GO:0033522) | 2.42396205 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39391019 |
| 102 | negative regulation of granulocyte differentiation (GO:0030853) | 2.39223275 |
| 103 | acrosome reaction (GO:0007340) | 2.38704155 |
| 104 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.38457838 |
| 105 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.38356645 |
| 106 | modulation by virus of host process (GO:0019054) | 2.37974101 |
| 107 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.37657338 |
| 108 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.35433823 |
| 109 | regulation of T cell tolerance induction (GO:0002664) | 2.35304188 |
| 110 | female gamete generation (GO:0007292) | 2.34653409 |
| 111 | negative regulation of meiosis (GO:0045835) | 2.34439864 |
| 112 | cell-cell junction maintenance (GO:0045217) | 2.32671815 |
| 113 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.31415951 |
| 114 | positive regulation of protein deacetylation (GO:0090312) | 2.31279996 |
| 115 | B cell receptor signaling pathway (GO:0050853) | 2.30483497 |
| 116 | response to type I interferon (GO:0034340) | 2.29988666 |
| 117 | modulation by symbiont of host cellular process (GO:0044068) | 2.29741780 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.29661966 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.29661966 |
| 120 | sodium ion export (GO:0071436) | 2.28436613 |
| 121 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.28254126 |
| 122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.26843985 |
| 123 | regulation of type 2 immune response (GO:0002828) | 2.26472063 |
| 124 | protein dealkylation (GO:0008214) | 2.26431514 |
| 125 | protein demethylation (GO:0006482) | 2.26431514 |
| 126 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.26306903 |
| 127 | COPI coating of Golgi vesicle (GO:0048205) | 2.26160173 |
| 128 | Golgi transport vesicle coating (GO:0048200) | 2.26160173 |
| 129 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.25890999 |
| 130 | positive regulation of extracellular matrix organization (GO:1903055) | 2.25403025 |
| 131 | adaptation of signaling pathway (GO:0023058) | 2.25325395 |
| 132 | activation of JUN kinase activity (GO:0007257) | 2.25124117 |
| 133 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.23958075 |
| 134 | NIK/NF-kappaB signaling (GO:0038061) | 2.23213088 |
| 135 | regulation of inclusion body assembly (GO:0090083) | 2.22303013 |
| 136 | regulation of RIG-I signaling pathway (GO:0039535) | 2.21502712 |
| 137 | natural killer cell differentiation (GO:0001779) | 2.21018422 |
| 138 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.20541579 |
| 139 | regulation of granulocyte differentiation (GO:0030852) | 2.20521164 |
| 140 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.20445107 |
| 141 | meiotic cell cycle (GO:0051321) | 2.20087943 |
| 142 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.19810672 |
| 143 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.19544535 |
| 144 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.18768750 |
| 145 | regulation of ARF GTPase activity (GO:0032312) | 2.18227750 |
| 146 | protein targeting to plasma membrane (GO:0072661) | 2.18186144 |
| 147 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.17793943 |
| 148 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.17635407 |
| 149 | regulation of leukocyte degranulation (GO:0043300) | 2.16960481 |
| 150 | cellular response to interleukin-15 (GO:0071350) | 2.16820360 |
| 151 | regulation of tolerance induction (GO:0002643) | 2.16625004 |
| 152 | diacylglycerol metabolic process (GO:0046339) | 2.16262792 |
| 153 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.15008666 |
| 154 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.15008666 |
| 155 | regulation of histone deacetylation (GO:0031063) | 2.14574192 |
| 156 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.14496720 |
| 157 | regulation of early endosome to late endosome transport (GO:2000641) | 2.14178223 |
| 158 | negative regulation of innate immune response (GO:0045824) | 2.13558394 |
| 159 | C21-steroid hormone metabolic process (GO:0008207) | 2.13148882 |
| 160 | regulation of mast cell degranulation (GO:0043304) | 2.13013910 |
| 161 | carnitine shuttle (GO:0006853) | 2.12530334 |
| 162 | multicellular organism reproduction (GO:0032504) | 2.12480955 |
| 163 | negative regulation of lipid transport (GO:0032369) | 2.12129151 |
| 164 | negative regulation of meiotic cell cycle (GO:0051447) | 2.11670091 |
| 165 | response to acidic pH (GO:0010447) | 2.11535743 |
| 166 | stress granule assembly (GO:0034063) | 2.10862411 |
| 167 | positive regulation of nuclease activity (GO:0032075) | 2.10556917 |
| 168 | stress fiber assembly (GO:0043149) | 2.09758215 |
| 169 | regulation of hippo signaling (GO:0035330) | 2.09638114 |
| 170 | response to peptidoglycan (GO:0032494) | 2.09247835 |
| 171 | detection of external biotic stimulus (GO:0098581) | 2.08896451 |
| 172 | male meiosis I (GO:0007141) | 2.07752963 |
| 173 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.07691683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.69919708 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.60932587 |
| 3 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.35826452 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.33446222 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23433963 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.22445537 |
| 7 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.20681081 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.20033647 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14116048 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.04375629 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98090206 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95909137 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93685692 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91456912 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83548755 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83453704 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82917167 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.78951026 |
| 19 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.76404669 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75793671 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.73089182 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71180035 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60656497 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59611716 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57868480 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55438873 |
| 27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55385640 |
| 28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.52605928 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.47765399 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47376901 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46974263 |
| 32 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.46781695 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46361563 |
| 34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45862994 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44475983 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43464155 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43096149 |
| 38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.41746452 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38977169 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36751782 |
| 41 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.34443155 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32999091 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31461383 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30285988 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30155859 |
| 46 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29228630 |
| 47 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28410750 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27864998 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26380410 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25850189 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.25597581 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25035325 |
| 53 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24960871 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24076515 |
| 55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.23195991 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22476666 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22344370 |
| 58 | * MYB_26560356_Chip-Seq_TH1_Human | 1.21757437 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21658058 |
| 60 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20942249 |
| 61 | * MYB_26560356_Chip-Seq_TH2_Human | 1.20549501 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19327434 |
| 63 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18743658 |
| 64 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.18087942 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17432964 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17287992 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16680920 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16469796 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16055826 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16055826 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15814137 |
| 72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13919490 |
| 73 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12967612 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11549684 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11388464 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11081940 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09778032 |
| 78 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09718976 |
| 79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08257063 |
| 80 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08101409 |
| 81 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07869689 |
| 82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07474578 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07366533 |
| 84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06952001 |
| 85 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06852039 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06834381 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06619231 |
| 88 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05824128 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.05557651 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05256332 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04598538 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04546002 |
| 93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03784129 |
| 94 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03492674 |
| 95 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02846710 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01835614 |
| 97 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01627882 |
| 98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01363440 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00892613 |
| 100 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99754357 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99036249 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99014569 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98924218 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98887488 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98799339 |
| 106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98669495 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 0.98454407 |
| 108 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.98147858 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98139454 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98003356 |
| 111 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97451325 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97294557 |
| 113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97200525 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96746862 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95682950 |
| 116 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95646993 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95482179 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94597260 |
| 119 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94185406 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93428729 |
| 121 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93247966 |
| 122 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92893490 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92520371 |
| 124 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.92364974 |
| 125 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91934117 |
| 126 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91747005 |
| 127 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.91589524 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90791121 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90034227 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89943772 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89438649 |
| 132 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.88696982 |
| 133 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88154680 |
| 134 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.87438590 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86712419 |
| 136 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86348302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 3.63853564 |
| 2 | MP0008961_abnormal_basal_metabolism | 3.44808333 |
| 3 | MP0005451_abnormal_body_composition | 3.16113427 |
| 4 | MP0002653_abnormal_ependyma_morphology | 3.00209154 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.98149701 |
| 6 | MP0004510_myositis | 2.62308163 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.56889845 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.47124493 |
| 9 | MP0001348_abnormal_lacrimal_gland | 2.43826308 |
| 10 | MP0003724_increased_susceptibility_to | 2.43011030 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.40952922 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.40051786 |
| 13 | MP0003303_peritoneal_inflammation | 2.13055370 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.04979580 |
| 15 | MP0009840_abnormal_foam_cell | 2.03643197 |
| 16 | MP0000685_abnormal_immune_system | 2.00584016 |
| 17 | MP0005365_abnormal_bile_salt | 1.97173884 |
| 18 | MP0005310_abnormal_salivary_gland | 1.97087536 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.90780607 |
| 20 | MP0009278_abnormal_bone_marrow | 1.89805957 |
| 21 | MP0002419_abnormal_innate_immunity | 1.87823673 |
| 22 | MP0008260_abnormal_autophagy | 1.82469526 |
| 23 | MP0005670_abnormal_white_adipose | 1.80122331 |
| 24 | MP0005025_abnormal_response_to | 1.76171591 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.74970057 |
| 26 | MP0002933_joint_inflammation | 1.74470756 |
| 27 | MP0003045_fibrosis | 1.72282294 |
| 28 | MP0003252_abnormal_bile_duct | 1.68970255 |
| 29 | MP0001790_abnormal_immune_system | 1.67839578 |
| 30 | MP0005387_immune_system_phenotype | 1.67839578 |
| 31 | MP0003279_aneurysm | 1.66494178 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.65237420 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.61819435 |
| 34 | MP0001800_abnormal_humoral_immune | 1.59818241 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.59292466 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.58538774 |
| 37 | MP0003878_abnormal_ear_physiology | 1.58538774 |
| 38 | MP0002132_abnormal_respiratory_system | 1.56028093 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.54015590 |
| 40 | MP0004130_abnormal_muscle_cell | 1.50075404 |
| 41 | MP0005410_abnormal_fertilization | 1.48707282 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.48029053 |
| 43 | MP0005360_urolithiasis | 1.47509596 |
| 44 | MP0002928_abnormal_bile_duct | 1.46228404 |
| 45 | MP0000678_abnormal_parathyroid_gland | 1.45507137 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.42257940 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.41090874 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.40782775 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.40606808 |
| 50 | MP0003828_pulmonary_edema | 1.40390280 |
| 51 | MP0001944_abnormal_pancreas_morphology | 1.40066149 |
| 52 | MP0003879_abnormal_hair_cell | 1.39481411 |
| 53 | MP0002693_abnormal_pancreas_physiology | 1.38372191 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.34016911 |
| 55 | MP0000639_abnormal_adrenal_gland | 1.33128066 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.31614188 |
| 57 | MP0005375_adipose_tissue_phenotype | 1.31046191 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.30461015 |
| 59 | MP0003699_abnormal_female_reproductive | 1.29858094 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.29710193 |
| 61 | MP0001929_abnormal_gametogenesis | 1.29004936 |
| 62 | MP0001873_stomach_inflammation | 1.28967615 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.26472439 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.26472439 |
| 65 | MP0005423_abnormal_somatic_nervous | 1.26250879 |
| 66 | MP0004858_abnormal_nervous_system | 1.25862510 |
| 67 | MP0000609_abnormal_liver_physiology | 1.24895430 |
| 68 | MP0009785_altered_susceptibility_to | 1.24304450 |
| 69 | MP0002168_other_aberrant_phenotype | 1.23955237 |
| 70 | MP0003329_amyloid_beta_deposits | 1.22271253 |
| 71 | MP0008569_lethality_at_weaning | 1.20960616 |
| 72 | MP0001958_emphysema | 1.18245195 |
| 73 | MP0001851_eye_inflammation | 1.17910641 |
| 74 | MP0003075_altered_response_to | 1.17132520 |
| 75 | MP0003690_abnormal_glial_cell | 1.15083324 |
| 76 | MP0002398_abnormal_bone_marrow | 1.14981714 |
| 77 | MP0001853_heart_inflammation | 1.13406014 |
| 78 | MP0001849_ear_inflammation | 1.12571349 |
| 79 | MP0005464_abnormal_platelet_physiology | 1.11450307 |
| 80 | MP0006082_CNS_inflammation | 1.10139856 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 1.09658148 |
| 82 | MP0002723_abnormal_immune_serum | 1.09442652 |
| 83 | MP0004947_skin_inflammation | 1.08736779 |
| 84 | MP0000013_abnormal_adipose_tissue | 1.08683298 |
| 85 | MP0002405_respiratory_system_inflammati | 1.08505259 |
| 86 | MP0005671_abnormal_response_to | 1.05852405 |
| 87 | MP0000249_abnormal_blood_vessel | 1.03351014 |
| 88 | MP0002822_catalepsy | 1.02434853 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 1.01754113 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.01443976 |
| 91 | MP0002452_abnormal_antigen_presenting | 1.00659681 |
| 92 | MP0003866_abnormal_defecation | 1.00520157 |
| 93 | MP0004036_abnormal_muscle_relaxation | 0.98313201 |
| 94 | MP0001819_abnormal_immune_cell | 0.98236817 |
| 95 | MP0005409_darkened_coat_color | 0.98010748 |
| 96 | MP0002971_abnormal_brown_adipose | 0.96927364 |
| 97 | MP0000716_abnormal_immune_system | 0.96890403 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.95564562 |
| 99 | MP0005390_skeleton_phenotype | 0.95413757 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.94915212 |
| 101 | MP0000689_abnormal_spleen_morphology | 0.94817685 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.93555510 |
| 103 | MP0002429_abnormal_blood_cell | 0.93222773 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.91833654 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.91761405 |
| 106 | MP0004381_abnormal_hair_follicle | 0.90840883 |
| 107 | MP0002148_abnormal_hypersensitivity_rea | 0.90572640 |
| 108 | MP0003091_abnormal_cell_migration | 0.89968439 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.89733855 |
| 110 | MP0009764_decreased_sensitivity_to | 0.89295995 |
| 111 | MP0005166_decreased_susceptibility_to | 0.88236091 |
| 112 | MP0005000_abnormal_immune_tolerance | 0.88087118 |
| 113 | MP0000751_myopathy | 0.87355024 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.87119439 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.86849585 |
| 116 | MP0008874_decreased_physiological_sensi | 0.85472941 |
| 117 | MP0008877_abnormal_DNA_methylation | 0.84715359 |
| 118 | MP0001119_abnormal_female_reproductive | 0.84524301 |
| 119 | MP0005395_other_phenotype | 0.84300356 |
| 120 | MP0003635_abnormal_synaptic_transmissio | 0.84125897 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.84017013 |
| 122 | MP0004859_abnormal_synaptic_plasticity | 0.82946426 |
| 123 | MP0002161_abnormal_fertility/fecundity | 0.82895814 |
| 124 | MP0000653_abnormal_sex_gland | 0.82657286 |
| 125 | MP0000858_altered_metastatic_potential | 0.81772005 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.80652142 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80358261 |
| 128 | MP0000604_amyloidosis | 0.80276913 |
| 129 | MP0003436_decreased_susceptibility_to | 0.79977129 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.79330896 |
| 131 | MP0010155_abnormal_intestine_physiology | 0.79224160 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.79186327 |
| 133 | MP0002269_muscular_atrophy | 0.78207898 |
| 134 | MP0005220_abnormal_exocrine_pancreas | 0.77900695 |
| 135 | MP0000920_abnormal_myelination | 0.77608267 |
| 136 | MP0008469_abnormal_protein_level | 0.77324482 |
| 137 | MP0002249_abnormal_larynx_morphology | 0.77102807 |
| 138 | MP0003868_abnormal_feces_composition | 0.74827871 |
| 139 | MP0002722_abnormal_immune_system | 0.74410303 |
| 140 | MP0005535_abnormal_body_temperature | 0.74267628 |
| 141 | MP0002970_abnormal_white_adipose | 0.74059551 |
| 142 | MP0003566_abnormal_cell_adhesion | 0.74024115 |
| 143 | MP0005085_abnormal_gallbladder_physiolo | 0.72511095 |
| 144 | MP0009115_abnormal_fat_cell | 0.71526412 |
| 145 | MP0002063_abnormal_learning/memory/cond | 0.69981415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Male infertility (HP:0003251) | 4.67654285 |
| 2 | Nasal polyposis (HP:0100582) | 4.49246179 |
| 3 | Abnormality of the nasal mucosa (HP:0000433) | 4.42642154 |
| 4 | Abnormality of the fingertips (HP:0001211) | 4.04646108 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.98366107 |
| 6 | Obstructive sleep apnea (HP:0002870) | 3.95443533 |
| 7 | Polycythemia (HP:0001901) | 3.41165044 |
| 8 | Cerebral aneurysm (HP:0004944) | 3.14677715 |
| 9 | Long toe (HP:0010511) | 3.10293419 |
| 10 | Infertility (HP:0000789) | 3.09118024 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.01558230 |
| 12 | Chronic bronchitis (HP:0004469) | 3.00747051 |
| 13 | Myositis (HP:0100614) | 2.93944207 |
| 14 | Abnormality of macrophages (HP:0004311) | 2.92660402 |
| 15 | Arterial tortuosity (HP:0005116) | 2.87853528 |
| 16 | Bronchitis (HP:0012387) | 2.86483579 |
| 17 | Aortic aneurysm (HP:0004942) | 2.85778304 |
| 18 | Colitis (HP:0002583) | 2.84557455 |
| 19 | Striae distensae (HP:0001065) | 2.77266946 |
| 20 | Recurrent bronchitis (HP:0002837) | 2.76974598 |
| 21 | Bundle branch block (HP:0011710) | 2.72697276 |
| 22 | Aneurysm (HP:0002617) | 2.72546877 |
| 23 | Neurofibrillary tangles (HP:0002185) | 2.70451701 |
| 24 | Broad face (HP:0000283) | 2.65755092 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 2.57265062 |
| 26 | Hyperacusis (HP:0010780) | 2.55720183 |
| 27 | Fatigue (HP:0012378) | 2.54499251 |
| 28 | Deep venous thrombosis (HP:0002625) | 2.54453723 |
| 29 | Abnormality of binocular vision (HP:0011514) | 2.53987013 |
| 30 | Diplopia (HP:0000651) | 2.53987013 |
| 31 | Cellulitis (HP:0100658) | 2.53869934 |
| 32 | Orchitis (HP:0100796) | 2.53118917 |
| 33 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.51382488 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.50597119 |
| 35 | Peripheral hypomyelination (HP:0007182) | 2.50141026 |
| 36 | Vascular tortuosity (HP:0004948) | 2.47164854 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.46514386 |
| 38 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.45001748 |
| 39 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.42696018 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 2.41571129 |
| 41 | Increased IgE level (HP:0003212) | 2.41492583 |
| 42 | Gingivitis (HP:0000230) | 2.41366154 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.39493142 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.38739091 |
| 45 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37849098 |
| 46 | Slow saccadic eye movements (HP:0000514) | 2.35554723 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.33670562 |
| 48 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31262212 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28833811 |
| 50 | Obstructive lung disease (HP:0006536) | 2.28833811 |
| 51 | Bronchiectasis (HP:0002110) | 2.26088447 |
| 52 | Spondylolisthesis (HP:0003302) | 2.24574456 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.23126252 |
| 54 | Myocardial infarction (HP:0001658) | 2.21565311 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21559801 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.21221038 |
| 57 | Hematochezia (HP:0002573) | 2.18986113 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.17785736 |
| 59 | Thin bony cortex (HP:0002753) | 2.16150647 |
| 60 | Severe visual impairment (HP:0001141) | 2.15925252 |
| 61 | Recurrent otitis media (HP:0000403) | 2.14078551 |
| 62 | Vasculitis (HP:0002633) | 2.13778305 |
| 63 | Optic neuritis (HP:0100653) | 2.13686215 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.13686215 |
| 65 | Hyperglycemia (HP:0003074) | 2.13031607 |
| 66 | Emphysema (HP:0002097) | 2.11017934 |
| 67 | Atrioventricular block (HP:0001678) | 2.10578143 |
| 68 | Enlarged penis (HP:0000040) | 2.10247640 |
| 69 | Ankle clonus (HP:0011448) | 2.09820118 |
| 70 | Deep palmar crease (HP:0006191) | 2.09695053 |
| 71 | Papillary thyroid carcinoma (HP:0002895) | 2.09355942 |
| 72 | Meningitis (HP:0001287) | 2.08029015 |
| 73 | Easy fatigability (HP:0003388) | 2.07970877 |
| 74 | Sensorimotor neuropathy (HP:0007141) | 2.07903904 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.05781148 |
| 76 | Gout (HP:0001997) | 2.05630829 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03764235 |
| 78 | EMG: neuropathic changes (HP:0003445) | 2.01374180 |
| 79 | Heterotopia (HP:0002282) | 2.01172559 |
| 80 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.00105442 |
| 81 | Villous atrophy (HP:0011473) | 2.00105442 |
| 82 | Pustule (HP:0200039) | 1.99858853 |
| 83 | Late onset (HP:0003584) | 1.97409265 |
| 84 | Ketoacidosis (HP:0001993) | 1.95421026 |
| 85 | Chronic otitis media (HP:0000389) | 1.94357644 |
| 86 | Mitral valve prolapse (HP:0001634) | 1.93669658 |
| 87 | Annular pancreas (HP:0001734) | 1.92908201 |
| 88 | Stomatitis (HP:0010280) | 1.92896798 |
| 89 | Onion bulb formation (HP:0003383) | 1.92102274 |
| 90 | Heart block (HP:0012722) | 1.91524211 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 1.90340342 |
| 92 | Hypochromic anemia (HP:0001931) | 1.89608416 |
| 93 | Chest pain (HP:0100749) | 1.88655943 |
| 94 | Aortic dissection (HP:0002647) | 1.88223062 |
| 95 | Growth hormone excess (HP:0000845) | 1.87703809 |
| 96 | Recurrent fungal infections (HP:0002841) | 1.86098057 |
| 97 | Ventricular fibrillation (HP:0001663) | 1.84963932 |
| 98 | Hemorrhage of the eye (HP:0011885) | 1.84639659 |
| 99 | Camptodactyly of toe (HP:0001836) | 1.84426608 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 1.83615359 |
| 101 | Agammaglobulinemia (HP:0004432) | 1.83522958 |
| 102 | Atelectasis (HP:0100750) | 1.82241801 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81891395 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81891395 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81891395 |
| 106 | Increased CSF protein (HP:0002922) | 1.80988449 |
| 107 | Pulmonary infiltrates (HP:0002113) | 1.80925603 |
| 108 | Abnormality of the aortic arch (HP:0012303) | 1.80859605 |
| 109 | Restrictive lung disease (HP:0002091) | 1.79958664 |
| 110 | Stridor (HP:0010307) | 1.79150030 |
| 111 | Insulin resistance (HP:0000855) | 1.77881524 |
| 112 | Mucopolysacchariduria (HP:0008155) | 1.77544358 |
| 113 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77544358 |
| 114 | Gastrointestinal infarctions (HP:0005244) | 1.76900871 |
| 115 | Rapidly progressive (HP:0003678) | 1.76837509 |
| 116 | Verrucae (HP:0200043) | 1.75580916 |
| 117 | Papilloma (HP:0012740) | 1.75580916 |
| 118 | Arterial thrombosis (HP:0004420) | 1.74782907 |
| 119 | Macroorchidism (HP:0000053) | 1.74667254 |
| 120 | Hypertriglyceridemia (HP:0002155) | 1.74490190 |
| 121 | Dysmetric saccades (HP:0000641) | 1.74325099 |
| 122 | Complement deficiency (HP:0004431) | 1.73498449 |
| 123 | Spontaneous hematomas (HP:0007420) | 1.73383469 |
| 124 | Cubitus valgus (HP:0002967) | 1.72907789 |
| 125 | Abnormal atrioventricular conduction (HP:0005150) | 1.72852773 |
| 126 | Cervical subluxation (HP:0003308) | 1.72650684 |
| 127 | Turricephaly (HP:0000262) | 1.72514703 |
| 128 | Ketosis (HP:0001946) | 1.72309854 |
| 129 | Anosmia (HP:0000458) | 1.71100435 |
| 130 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.69501421 |
| 131 | Distal lower limb amyotrophy (HP:0008944) | 1.68574724 |
| 132 | Papilledema (HP:0001085) | 1.67915064 |
| 133 | Epistaxis (HP:0000421) | 1.67861219 |
| 134 | Hand muscle atrophy (HP:0009130) | 1.67821368 |
| 135 | Global brain atrophy (HP:0002283) | 1.67787578 |
| 136 | Episodic fever (HP:0001954) | 1.67511730 |
| 137 | Metaphyseal cupping (HP:0003021) | 1.66623443 |
| 138 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.66340941 |
| 139 | Peritonitis (HP:0002586) | 1.65473916 |
| 140 | Shawl scrotum (HP:0000049) | 1.65379633 |
| 141 | Recurrent sinusitis (HP:0011108) | 1.65171940 |
| 142 | Hypercortisolism (HP:0001578) | 1.63974997 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.63310171 |
| 144 | Stereotypic behavior (HP:0000733) | 1.63188722 |
| 145 | Hemiplegia (HP:0002301) | 1.63092256 |
| 146 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.62786988 |
| 147 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.62786988 |
| 148 | Acne (HP:0001061) | 1.62680760 |
| 149 | Increased connective tissue (HP:0009025) | 1.62642423 |
| 150 | Distal upper limb amyotrophy (HP:0007149) | 1.61527102 |
| 151 | Upper limb amyotrophy (HP:0009129) | 1.61527102 |
| 152 | Recurrent skin infections (HP:0001581) | 1.60911310 |
| 153 | Increased variability in muscle fiber diameter (HP:0003557) | 1.60885977 |
| 154 | Neuronal loss in central nervous system (HP:0002529) | 1.60865842 |
| 155 | Amyloidosis (HP:0011034) | 1.60603780 |
| 156 | Narrow palate (HP:0000189) | 1.60597312 |
| 157 | Polygenic inheritance (HP:0010982) | 1.60272344 |
| 158 | Decreased motor nerve conduction velocity (HP:0003431) | 1.60170420 |
| 159 | Spinal canal stenosis (HP:0003416) | 1.59808705 |
| 160 | Neoplasm of the heart (HP:0100544) | 1.58929707 |
| 161 | Protrusio acetabuli (HP:0003179) | 1.58152634 |
| 162 | Difficulty running (HP:0009046) | 1.57670428 |
| 163 | T lymphocytopenia (HP:0005403) | 1.56334549 |
| 164 | Precocious puberty (HP:0000826) | 1.55125552 |
| 165 | Postural instability (HP:0002172) | 1.53876934 |
| 166 | Loss of speech (HP:0002371) | 1.53773678 |
| 167 | Panhypogammaglobulinemia (HP:0003139) | 1.53558285 |
| 168 | Hyperkalemia (HP:0002153) | 1.53484971 |
| 169 | Exercise-induced myalgia (HP:0003738) | 1.53377198 |
| 170 | Sandal gap (HP:0001852) | 1.53216103 |
| 171 | Lip pit (HP:0100267) | 1.52830555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KSR2 | 3.16318355 |
| 2 | TAOK1 | 3.12637286 |
| 3 | PRPF4B | 3.08195748 |
| 4 | TAOK3 | 3.07977121 |
| 5 | EEF2K | 2.95902786 |
| 6 | TRIB3 | 2.95108059 |
| 7 | MAP3K13 | 2.82556444 |
| 8 | MAP3K9 | 2.72971983 |
| 9 | LATS1 | 2.56664464 |
| 10 | PRKD3 | 2.48505925 |
| 11 | RIPK4 | 2.47253755 |
| 12 | MAP4K1 | 2.33941207 |
| 13 | ERN1 | 2.22228457 |
| 14 | LATS2 | 2.00375161 |
| 15 | MAP3K6 | 1.89087289 |
| 16 | PRKD2 | 1.82858589 |
| 17 | STK38 | 1.75099264 |
| 18 | TESK1 | 1.72608420 |
| 19 | MOS | 1.66252508 |
| 20 | MAPKAPK3 | 1.63173326 |
| 21 | SIK3 | 1.53260484 |
| 22 | TNK2 | 1.50979785 |
| 23 | BLK | 1.49711157 |
| 24 | DDR2 | 1.49528083 |
| 25 | MARK2 | 1.48693666 |
| 26 | MAP2K3 | 1.48030953 |
| 27 | PAK6 | 1.42643219 |
| 28 | HIPK2 | 1.40235048 |
| 29 | RAF1 | 1.36757668 |
| 30 | PKN2 | 1.35260361 |
| 31 | IRAK4 | 1.34493931 |
| 32 | JAK3 | 1.30384033 |
| 33 | UHMK1 | 1.27871058 |
| 34 | JAK1 | 1.27160703 |
| 35 | PRKCH | 1.26494309 |
| 36 | STK10 | 1.25952133 |
| 37 | MAP3K10 | 1.25155308 |
| 38 | TYK2 | 1.24958968 |
| 39 | FGFR4 | 1.22678586 |
| 40 | CDC42BPA | 1.21877131 |
| 41 | MAP3K11 | 1.21618209 |
| 42 | RET | 1.21426456 |
| 43 | MAPK15 | 1.18751665 |
| 44 | DMPK | 1.17843810 |
| 45 | TYRO3 | 1.13828291 |
| 46 | FES | 1.11605759 |
| 47 | RIPK1 | 1.11587972 |
| 48 | STK38L | 1.10657625 |
| 49 | MAP3K1 | 1.10041575 |
| 50 | MAP3K3 | 1.00444333 |
| 51 | SIK1 | 1.00368460 |
| 52 | BRD4 | 0.99861149 |
| 53 | JAK2 | 0.98361760 |
| 54 | TGFBR2 | 0.97562711 |
| 55 | MAP3K14 | 0.96178390 |
| 56 | CDK9 | 0.95629031 |
| 57 | TXK | 0.94948580 |
| 58 | ZAP70 | 0.94501166 |
| 59 | SMG1 | 0.93971962 |
| 60 | SIK2 | 0.91849260 |
| 61 | ERBB4 | 0.90933943 |
| 62 | MAP3K7 | 0.89951535 |
| 63 | RPS6KA2 | 0.88664781 |
| 64 | GRK6 | 0.87709836 |
| 65 | TTN | 0.87707486 |
| 66 | ITK | 0.83748676 |
| 67 | IRAK3 | 0.83426002 |
| 68 | ICK | 0.83170778 |
| 69 | MUSK | 0.82600908 |
| 70 | PDGFRA | 0.82538349 |
| 71 | NLK | 0.80382802 |
| 72 | EPHB1 | 0.78976474 |
| 73 | CAMK1G | 0.77947546 |
| 74 | SGK3 | 0.76443489 |
| 75 | RPS6KC1 | 0.74865435 |
| 76 | RPS6KL1 | 0.74865435 |
| 77 | STK3 | 0.73336137 |
| 78 | PDGFRB | 0.72875725 |
| 79 | PDK1 | 0.72249931 |
| 80 | ARAF | 0.72235071 |
| 81 | FGFR3 | 0.72137470 |
| 82 | MAP2K2 | 0.71106131 |
| 83 | SYK | 0.70617503 |
| 84 | NEK2 | 0.70568118 |
| 85 | PRKAA1 | 0.70458175 |
| 86 | MAPK7 | 0.70094695 |
| 87 | BMX | 0.69808115 |
| 88 | PTK2 | 0.68728964 |
| 89 | TAOK2 | 0.68078252 |
| 90 | PRKAA2 | 0.65824414 |
| 91 | MAP3K2 | 0.65282019 |
| 92 | CAMKK1 | 0.65278280 |
| 93 | PTK6 | 0.65265657 |
| 94 | KSR1 | 0.63904740 |
| 95 | NTRK3 | 0.63816282 |
| 96 | MELK | 0.63357792 |
| 97 | IKBKE | 0.63029934 |
| 98 | PDK3 | 0.61532747 |
| 99 | PDK4 | 0.61532747 |
| 100 | RPS6KA6 | 0.59478732 |
| 101 | IKBKB | 0.59140090 |
| 102 | MAPK11 | 0.59066277 |
| 103 | IRAK2 | 0.58466967 |
| 104 | CAMK1D | 0.58179882 |
| 105 | PDPK1 | 0.57851305 |
| 106 | BMPR2 | 0.57203842 |
| 107 | LCK | 0.56577871 |
| 108 | HCK | 0.56059632 |
| 109 | CSK | 0.55057946 |
| 110 | EPHA3 | 0.53930057 |
| 111 | WNK4 | 0.53195149 |
| 112 | MAPK4 | 0.53051887 |
| 113 | PINK1 | 0.52644125 |
| 114 | LRRK2 | 0.52354630 |
| 115 | STK11 | 0.51871544 |
| 116 | SGK223 | 0.51028546 |
| 117 | SGK494 | 0.51028546 |
| 118 | PRKD1 | 0.50707594 |
| 119 | CAMK4 | 0.50314637 |
| 120 | NTRK2 | 0.47682665 |
| 121 | MARK3 | 0.47239510 |
| 122 | CHUK | 0.47188763 |
| 123 | CDK12 | 0.46748157 |
| 124 | MTOR | 0.46107682 |
| 125 | RPS6KA1 | 0.45742587 |
| 126 | TBK1 | 0.45347746 |
| 127 | INSRR | 0.45245414 |
| 128 | MAP3K4 | 0.44973848 |
| 129 | CAMK1 | 0.44695922 |
| 130 | PTK2B | 0.44677708 |
| 131 | SGK2 | 0.44271440 |
| 132 | MAP2K6 | 0.43749022 |
| 133 | MAP2K4 | 0.43446285 |
| 134 | BTK | 0.41898286 |
| 135 | LMTK2 | 0.40548670 |
| 136 | NTRK1 | 0.40209469 |
| 137 | PAK3 | 0.40029281 |
| 138 | WNK1 | 0.35939495 |
| 139 | DYRK1B | 0.35288484 |
| 140 | MAPK12 | 0.35222252 |
| 141 | BRAF | 0.32349264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.97734202 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 1.71100273 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67956883 |
| 4 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.61693227 |
| 5 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.59426602 |
| 6 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.55161715 |
| 7 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.53179112 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.52580081 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50508024 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.44784828 |
| 11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43600044 |
| 12 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.41540842 |
| 13 | Insulin resistance_Homo sapiens_hsa04931 | 1.41224944 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41049319 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41020812 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39098854 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.37150866 |
| 18 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34893348 |
| 19 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.34386437 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31845621 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25011303 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24757863 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24477036 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24146595 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21218648 |
| 26 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19811625 |
| 27 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.18169817 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16793125 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.16643055 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14093389 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.13267929 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11952931 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09863189 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09134412 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.07754867 |
| 36 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.06705507 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.06394805 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04266015 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.03678014 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02308450 |
| 41 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01063551 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00064581 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99601637 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97369565 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97118793 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96456316 |
| 47 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.95887898 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94774010 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93646765 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92686135 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92405672 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91500164 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.90362535 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90252803 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.89214799 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89091727 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88492586 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87537117 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.86021204 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85681268 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85557450 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84799606 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84071373 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83506937 |
| 65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82713199 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.82609965 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.82377538 |
| 68 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.81788559 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81621128 |
| 70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81486759 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80362682 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.79935809 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79552764 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78891139 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78535338 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78220304 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78035237 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77045451 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76920911 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76810516 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.76355505 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.76212544 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75992858 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75878872 |
| 85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75835444 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74514057 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74432328 |
| 88 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73632579 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73233825 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72946999 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72900853 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.72745248 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68268040 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68214934 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67150819 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.66511103 |
| 97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66434827 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.66338560 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65654400 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.65367664 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65313137 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65250978 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64682908 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.64156011 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63532454 |
| 106 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63192997 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62844308 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62266378 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.61794749 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61479800 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.60896671 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60753007 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60713211 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59777473 |
| 115 | Adherens junction_Homo sapiens_hsa04520 | 0.59541629 |
| 116 | Morphine addiction_Homo sapiens_hsa05032 | 0.58863940 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58502211 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58402623 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.58357681 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57744123 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57704542 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57419859 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56690343 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.56454133 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56448256 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.56361495 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56306363 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.54623876 |
| 129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54477208 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54033837 |
| 131 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48488753 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47638494 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45496924 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45453390 |
| 135 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45353953 |

